Can a website make your doctor visit faster and clearer?
NCT ID NCT07580391
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a web-based tool called WellPrept that gives patients clear information before their urology procedures. Researchers want to see if it helps patients feel more confident and understand their condition better, and if it shortens clinic visits. About 300 men and women having prostate or kidney stone surgery are taking part.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- WellPrept web-based application
- What this could lead to
- If successful, this could show that a simple web tool helps patients feel more informed and reduces time spent in clinic visits.
- What could go wrong
- This is an early-stage study focused on education, not a new treatment. The web app may not significantly improve outcomes or reduce emergency visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * In the HoLEP arm, men aged 18-100 who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms, that are typically caused by enlarged prostates. * In the Kidney stone arm, men and women aged 18-100 who are undergoing surgery for the treatment of stones in the kidney, urinary tract, or bladder. Exclusion Criteria: * Patients with prostates measurements over 200g * Patients who lack decisional capacity * Patients who are non-English speakers
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One surgery or two? trial tests prostate removal during bladder stone operation
- Which emergency drainage gives the best kidney stone surgery results?
- Laser prostate surgery that spares ejaculation put to a Five-Year test
- Virtual basket laser mode put to the test for faster prostate surgery
- Steam therapy vs. surgery: can a less invasive fix help men with blocked urine flow?
- Listening to patients: a new way to guide prostate treatment?